CaHA vs PLLA
This page places verifiable specifications side by side. It does not rank materials, score them, or recommend one over another.
Comparison
What is the difference between CaHA and PLLA as collagen biostimulators?
The two materials belong to different chemical families: CaHA is a calcium phosphate ceramic whose mineral phase matches the inorganic component of bone, while PLLA is a synthetic polyester that hydrolyses to lactic acid. Both are described in the literature as scaffolds that provoke a fibroblast response rather than as materials that supply collagen. They are handled the same way in Korea and the European Union; in the United States only PLLA could be established from public records.
| Aspect | CaHA (Calcium hydroxylapatite) | PLLA (Poly-L-lactic acid) | Basis |
|---|---|---|---|
| Chemical family | Calcium phosphate ceramic | Aliphatic polyester | — |
| Composition note | Mineral phase chemically identical to the inorganic component of bone | Hydrolyses to lactic acid monomers | — |
| Particle form described | Smooth spherical ceramic particles suspended in a carrier gel | Semi-crystalline microparticles; injectable forms described as lyophilised powder reconstituted before use | — |
| Preparation before use | Supplied in a carrier gel; dilution varies between published protocols | Reconstitution volume and waiting interval vary between published protocols | — |
| Regulatory identity — Korea | Medical device, tissue-repair biomaterial route | Medical device, tissue-repair biomaterial route | Legal text |
| Regulatory identity — European Union | Medical device under MDR Annex XVI, Section 3 | Medical device under MDR Annex XVI, Section 3 | Legal text |
| Regulatory identity — United States | Not established from public sources | Device pathway; an injectable implant holds premarket approval PMA P030050 | Legal text |
| Highest-tier evidence cited on this site | Systematic and narrative reviews (PMID 37332763, 37635437) | Randomised controlled trial (PMID 38206151) | — |
| Study placing both side by side | Morphological comparison of CaHA and PLLA particles (PMID 38853456) | Morphological comparison of CaHA and PLLA particles (PMID 38853456); systematic review covering both (PMID 41184662) | — |
Different chemistry, similar description of what follows
A ceramic and a polyester have little in common as materials, yet the literature describes their tissue behaviour in similar terms: a particle acts as a scaffold, fibroblasts respond, matrix is deposited. The difference that does carry through is what the particle leaves behind — PLLA hydrolyses to lactic acid, while CaHA is a mineral whose phase matches the inorganic part of bone.
Two studies do look at both
Most of this table is assembled from separate literature, but two citations examine both materials in one place: a morphological analysis comparing the particles, and a systematic review covering PLLA- and CaHA-based biostimulators in the face. Neither is a randomised clinical comparison, so they establish shared description rather than relative clinical result.
The regulatory rows are not symmetric
In Korea and the European Union the two follow the same route. In the United States an injectable PLLA implant carries premarket approval on the device pathway, while for CaHA no equivalent record was established from public sources here. That asymmetry is about what could be verified, not about the materials themselves.
Limitations & open questions
The evidence bases are not of the same tier. The CaHA literature cited here is review-level, while PLLA has a randomised trial among the citations, so the two rows are not equivalent in strength of design. One morphological study and one systematic review do examine both materials, but neither is a randomised head-to-head clinical comparison. Dilution and placement depth vary widely in practice for CaHA and are not standardised in the literature.